Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany.

Rui CaiLaetitia Gerlier Martin Eichner Markus Schwehm Sankarasubramanian RajaramJoaquin Mould-QuevedoMark Lamotte

Published in: Journal of medical economics (2021)

The use of QIVc compared to QIVe, in the German Immunization Program, could significantly prevent outpatient visits and hospitalizations and would enable substantial savings from a societal perspective.

Keyphrases

single cell
cell therapy
quality improvement
bone marrow